Singular Genomics And TwinStrand Biosciences Collaborate To Develop NGS Solutions For The G4 Platform
Singular Genomics Systems Inc. (NASDAQ:OMIC) and TwinStrand Biosciences, Inc. today announced a collaboration to develop highly sensitive next generation sequencing (NGS) solutions for the Singular G4 Sequencing Platform